Helene Mathilde Larsen

Helene Mathilde Larsen

Auto-generated profile, based on publicly available information

Helene Mathilde Larsen

Department of Surgery, Aarhus University Hospital, Aarhus, Denmark

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MMMira Mekhael
Mira Mekhael
HKHelle Ø Kristensen
Helle Ø Kristensen
HLHelene Mathilde Larsen
Helene Mathilde Larsen
TJTherese Juul
Therese Juul
AEAnton Emmanuel
Anton Emmanuel
PCPeter Christensen
Peter Christensen
Transanal irrigation (TAI) has received increasing attention as a treatment option in patients with bowel dysfunction. This systematic review was conducted according to the PRISMA guidelines and evaluates the effect of TAI in neurogenic bowel dysfunction (NBD), low anterior resection syndrome (LARS), faecal incontinence (FI) and chronic constipation (CC). The primary outcome was the effect of TAI on bowel function. Secondary outcomes included details on TAI, quality of life (QoL), the discontinuation rate, adverse events, predictive factors for a successful outcome, and health economics. A systematic search for articles reporting original data on the effect of TAI on bowel function was performed, and 27 eligible studies including 1435 individuals were included. Three randomised controlled trials, one non-randomised trial, and 23 observational studies were included; 70% of the studies were assessed to be of excellent or good methodological quality. Results showed an improvement in bowel function among patients with NBD, LARS, FI, and CC with some studies showing improvement in QoL. However, discontinuation rates were high. Side effects were common, but equally prevalent among comparative treatments. No consistent predictive factors for a successful outcome were identified. Results from this review show that TAI improves bowel function and potentially QoL; however, evidence remains limited.

28 January 2021 in Colorectal Disease
Verified
Journal Article
Closed access
PDF file
HLHelene M. Larsen
Helene M. Larsen
MMMira Mekhael
Mira Mekhael
TJTherese Juul
Therese Juul
MBMette Borre
Mette Borre
PCPeter Christensen
Peter Christensen
DGDanish Cancer Society Centre for Research on Survivorship and Late Adverse Effects after Cancer in the Pelvic Organs Study Group
Danish Cancer Society Centre for Research on Survivorship and Late Adverse Effects after Cancer in the Pelvic Organs Study Group

23 November 2022 in Colorectal Disease
Verified
Journal Article
Open access
HLHelene Mathilde Larsen
Helene Mathilde Larsen
KKKlaus Krogh
Klaus Krogh
MBMette Borre
Mette Borre
TGTine Gregersen
Tine Gregersen
MHMette Mejlby Hansen
Mette Mejlby Hansen
JFJanne Ladefoged Fassov
Janne Ladefoged Fassov
Aim: Patients treated with right‐sided hemicolectomy for colon cancer may suffer from long‐term bowel dysfunction, including loose stools, urgency and faecal incontinence. The underlying causes are poorly understood. The aim of this case–control study was to investigate the aetiology of chronic loose stools among patients with right‐sided hemicolectomy curatively operated for cancer.Method: Cases with chronic loose stools (Bristol stool type 6–7) after right‐sided hemicolectomy were compared with a control group of patients with right‐sided hemicolectomy without loose stools. All patients underwent a selenium‐75 homocholic acid taurine (SeHCAT) scan to diagnose bile acid malabsorption (BAM) and a glucose breath test to diagnose small intestinal bacterial overgrowth (SIBO). Gastrointestinal transit time (GITT) was assessed with radiopaque markers. In a subgroup of patients, fibroblast growth factor 19 (FGF19) was measured in fasting blood. SIBO was treated with antibiotics and BAM was treated with bile acid sequestrants.Results: We included 45 cases and 19 controls. In the case group, 82% (n = 36) had BAM compared with 37% (n = 7) in the control group, p < 0.001. SIBO was diagnosed in 73% (n = 33) of cases with chronic loose stools and in 74% (n = 14) of controls, p = 0.977. No association between BAM and SIBO was observed. GITT was similar in cases and controls. No difference in median FGF19 was observed between cases and controls (p = 0.894), and no correlation was seen between FGF19 and SeHCAT retention (rs 0.20, p = 0.294). Bowel symptoms among cases were reduced after treatment.Conclusion: BAM and SIBO are common in patients having undergone right‐sided hemicolectomy for cancer. Chronic loose stools were associated with BAM but not with SIBO.

5 June 2020 in Acta Oncologica
Verified
Journal Article
Closed access
HLHelene Mathilde Larsen
Helene Mathilde Larsen
HEHossam Elfeki
Hossam Elfeki
KEKatrine Jøssing Emmertsen
Katrine Jøssing Emmertsen
SLSøren Laurberg
Søren Laurberg
Functional outcome following treatment for colorectal cancer has received increasing attention, and it has been shown that bowel dysfunction is very common after rectal resection. However, little i...

2 January 2023 in Acta Oncologica
Verified
Journal Article
Closed access
MMMira Mekhael
Mira Mekhael
HLHelene M. Larsen
Helene M. Larsen
MLMichael B. Lauritzen
Michael B. Lauritzen
OTOle Thorlacius-Ussing
Ole Thorlacius-Ussing
SLSøren Laurberg
Søren Laurberg
TJTherese Juul
Therese Juul
Background: Bowel dysfunction following treatment of pelvic organ cancer is prevalent and impacts the quality of life (QoL). The present study aimed to evaluate the feasibility and effects of treating bowel dysfunction in two nurse-led late sequelae clinics. Material and methods: Treatment effects were monitored prospectively by patient-reported outcome measures collected at baseline and discharge. Change in bowel function was evaluated by 15 bowel symptoms, the St. Mark’s Incontinence Score, the Patients Assessment of Constipation-Symptoms (PAC-SYM) score and self-rated bowel function. QoL was evaluated by the EuroQol 5-dimension 5-level (EQ-5D-5L) utility score and by measuring the impact of bowel function on QoL. Results: From June 2018 to December 2021, 380 cancer survivors (46% rectal, 15% gynaecological, 13% anal, 12% colon, 12% prostate, and 2% other cancers) completed a baseline questionnaire and started treatment for bowel dysfunction. At referral, 96% of patients were multisymptomatic. The most frequent symptoms were faecal urgency (95%), fragmented defaecation (93%), emptying difficulties (92%), flatus/faecal incontinence (flatus 89%, liquid 59%, solid 33%), and obstructed defaecation (79%). In total, 169 patients were discharged from the clinics in the follow-up period. At discharge, 69% received conservative treatment only and 24% also received transanal irrigation; 4% were surgically treated; 3% discontinued treatment. Improvements were seen in all 15 bowel symptoms (p < 0.001), the mean St. Mark’s Incontinence Score (12.0 to 9.9, p < 0.001), the mean PAC-SYM score (1.04 to 0.84, p < 0.001) and the mean EQ-5D-5L utility score (0.78 to 0.84, p < 0.001). Self-rated bowel function improved in 56% (p < 0.001) of cases and the impact of bowel function on QoL improved in 46% (p < 0.001). Conclusion: Treatment of bowel dysfunction in nurse-led late sequelae clinics is feasible and significantly improved bowel function and QoL.